Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0QP7C
|
||||
Former ID |
DNC006827
|
||||
Drug Name |
4-hydroxy-6-nitro-3-phenylquinolin-2(1H)-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528261] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H10N2O4
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C2=C(C3=C(C=CC(=C3)[N+](=O)[O-])NC2=O)O
|
||||
InChI |
1S/C15H10N2O4/c18-14-11-8-10(17(20)21)6-7-12(11)16-15(19)13(14)9-4-2-1-3-5-9/h1-8H,(H2,16,18,19)
|
||||
InChIKey |
FHJYCGCXAYLWFD-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty acid synthase | Target Info | Inhibitor | [528261] | |
Pathway Interaction Database | p73 transcription factor network | ||||
Validated transcriptional targets of deltaNp63 isoforms | |||||
PathWhiz Pathway | Fatty Acid Biosynthesis | ||||
WikiPathways | Fatty Acid Biosynthesis | ||||
Nuclear Receptors Meta-Pathway | |||||
Liver X Receptor Pathway | |||||
Activation of Gene Expression by SREBP (SREBF) | |||||
SREBF and miR33 in cholesterol and lipid homeostasis | |||||
SREBP signalling | |||||
Metabolism of water-soluble vitamins and cofactors | |||||
Integration of energy metabolism | |||||
Fatty acid, triacylglycerol, and ketone body metabolism | |||||
AMPK Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.